Treatment of
type 2 diabetes with the designer cytokine IC7Fc
Funding
This study was funded, in part, by the National Health & Medical Research Council of Australia (Project Grant 526606 and APP1156511 to MAF and SR-J; Project Grant APP1039502 to MAF; Development Grant APP1039502 to MAF, TEA, MAC; Principal Research Fellowship 445302 to MAF, Senior Principal Research Fellowship (SPRF) APP1021168 to MAF, SPRF APP1116936 to MAF).